Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Aerosolization of second-generation triazoles: In vitro evaluation and application in therapy of invasive airway aspergillosis.

Thanukrishnan H, Corcoran TE, Iasella CJ, Moore CA, Nero JA, Morrell MR, McDyer JF, Hussain S, Nguyen MH, Venkataramanan R, Ensor CR.

Transplantation. 2019 Mar 4. doi: 10.1097/TP.0000000000002697. [Epub ahead of print]

PMID:
31343565
2.

Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT.

Verleden GM, Glanville AR, Lease ED, Fisher AJ, Calabrese F, Corris PA, Ensor CR, Gottlieb J, Hachem RR, Lama V, Martinu T, Neil DAH, Singer LG, Snell G, Vos R.

J Heart Lung Transplant. 2019 May;38(5):493-503. doi: 10.1016/j.healun.2019.03.009. Epub 2019 Apr 3. No abstract available.

PMID:
30962148
3.

Cytokine-targeted therapy for the management of solid organ transplant recipients.

Szczepanik A, Iasella CJ, McDyer JF, Ensor CR.

Hum Immunol. 2019 Mar;80(3):184-190. doi: 10.1016/j.humimm.2018.12.006. Epub 2018 Dec 16. Review.

PMID:
30562564
4.

Detrimental Association of Hypogammaglobulinemia With Chronic Lung Allograft Dysfunction and Death Is Not Mitigated by On-Demand Immunoglobulin G Replacement After Lung Transplantation.

Lichvar AB, Ensor CR, Zeevi A, Morrell MR, Pilewski JM, Hayanga JWA, D'Cunha J, McDyer JF, Petrov AA.

Prog Transplant. 2018 Dec 11:1526924818817028. doi: 10.1177/1526924818817028. [Epub ahead of print]

PMID:
30537897
5.

Outcomes after lung transplantation for patients with occupational lung diseases.

Joubert KD, Awori Hayanga J, Strollo DC, Lendermon EA, Yousem SA, Luketich JD, Ensor CR, Shigemura N.

Clin Transplant. 2019 Jan;33(1):e13460. doi: 10.1111/ctr.13460. Epub 2018 Dec 30.

PMID:
30506808
6.

A Prospective Observational Study of Hypogammaglobulinemia in the First Year After Lung Transplantation.

Petrov AA, Traister RS, Crespo MM, Silveira FP, Xie M, Coffey K, Ensor CR, Landsittel D, Pilewski JM.

Transplant Direct. 2018 Jul 12;4(8):e372. doi: 10.1097/TXD.0000000000000811. eCollection 2018 Aug.

7.

Impaired Cytomegalovirus Immunity in Idiopathic Pulmonary Fibrosis Lung Transplant Recipients with Short Telomeres.

Popescu I, Mannem H, Winters SA, Hoji A, Silveira F, McNally E, Pipeling MR, Lendermon EA, Morrell MR, Pilewski JM, Hanumanthu VS, Zhang Y, Gulati S, Shah PD, Iasella CJ, Ensor CR, Armanios M, McDyer JF.

Am J Respir Crit Care Med. 2019 Feb 1;199(3):362-376. doi: 10.1164/rccm.201805-0825OC.

PMID:
30088779
8.

Belatacept for maintenance immunosuppression in cardiothoracic transplantation: The potential frontier.

Ensor CR, Goehring KC, Iasella CJ, Moore CA, Lendermon EA, McDyer JF, Morrell MR, Sciortino CM, Venkataramanan R, Wiland AM.

Clin Transplant. 2018 Oct;32(10):e13363. doi: 10.1111/ctr.13363. Epub 2018 Sep 10. Review.

PMID:
30058177
9.

Azithromycin Fails to Prevent Accelerated Airway Obliteration in T-bet-/- Mouse Lung Allograft Recipients.

Lendermon EA, Dodd-O JM, Coon TA, Wang X, Ensor CR, Cardenes N, Koodray CL, Heusey HL, Bennewitz MF, Sundd P, Bullock GC, Popescu I, Guo L, O'Donnell CP, Rojas M, McDyer JF.

Transplant Proc. 2018 Jun;50(5):1566-1574. doi: 10.1016/j.transproceed.2018.02.070. Epub 2018 Mar 9.

PMID:
29880387
10.

Systematic review and meta-analysis of post-transplant lymphoproliferative disorder in lung transplant recipients.

Cheng J, Moore CA, Iasella CJ, Glanville AR, Morrell MR, Smith RB, McDyer JF, Ensor CR.

Clin Transplant. 2018 May;32(5):e13235. doi: 10.1111/ctr.13235. Epub 2018 Mar 30.

11.

Increasing tacrolimus time-in-therapeutic range is associated with superior one-year outcomes in lung transplant recipients.

Ensor CR, Iasella CJ, Harrigan KM, Morrell MR, Moore CA, Shigemura N, Zeevi A, McDyer JF, Venkataramanan R.

Am J Transplant. 2018 Jun;18(6):1527-1533. doi: 10.1111/ajt.14723. Epub 2018 Apr 6.

12.

Maintenance Belatacept-Based Immunosuppression in Lung Transplantation Recipients Who Failed Calcineurin Inhibitors.

Iasella CJ, Winstead RJ, Moore CA, Johnson BA, Feinberg AT, Morrell MR, Hayanga JWA, Lendermon EA, Zeevi A, McDyer JF, Ensor CR.

Transplantation. 2018 Jan;102(1):171-177. doi: 10.1097/TP.0000000000001873.

PMID:
28691954
13.

Effects of Isavuconazole on the Plasma Concentrations of Tacrolimus among Solid-Organ Transplant Patients.

Rivosecchi RM, Clancy CJ, Shields RK, Ensor CR, Shullo MA, Falcione BA, Venkataramanan R, Nguyen MH.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00970-17. doi: 10.1128/AAC.00970-17. Print 2017 Sep.

14.

Comparative Effectiveness and Safety Analysis of Dual Antiplatelet Therapies Within an Integrated Delivery System.

Coons JC, Iasella CJ, Chanas T, Wang N, Williams K, Boyd A, Lyons J, Eckardt J, Rihtarchik L, Merkel A, Chambers A, Lemon LS, Smith R, Ensor CR.

Ann Pharmacother. 2017 Aug;51(8):649-655. doi: 10.1177/1060028017706977. Epub 2017 Apr 24.

PMID:
28438043
15.

Effect of aerosolized antipseudomonals on Pseudomonas positivity and bronchiolitis obliterans syndrome after lung transplantation.

Moore CA, Pilewski JM, Venkataramanan R, Robinson KM, Morrell MR, Wisniewski SR, Zeevi A, McDyer JF, Ensor CR.

Transpl Infect Dis. 2017 Jun;19(3). doi: 10.1111/tid.12688. Epub 2017 Apr 17.

PMID:
28273385
16.

Proteasome Inhibitor Carfilzomib-Based Therapy for Antibody-Mediated Rejection of the Pulmonary Allograft: Use and Short-Term Findings.

Ensor CR, Yousem SA, Marrari M, Morrell MR, Mangiola M, Pilewski JM, D'Cunha J, Wisniewski SR, Venkataramanan R, Zeevi A, McDyer JF.

Am J Transplant. 2017 May;17(5):1380-1388. doi: 10.1111/ajt.14222. Epub 2017 Mar 9.

17.

Rescue alemtuzumab for refractory acute cellular rejection and bronchiolitis obliterans syndrome after lung transplantation.

Ensor CR, Rihtarchik LC, Morrell MR, Hayanga JW, Lichvar AB, Pilewski JM, Wisniewski S, Johnson BA, D'Cunha J, Zeevi A, McDyer JF.

Clin Transplant. 2017 Apr;31(4). doi: 10.1111/ctr.12899. Epub 2017 Feb 22.

PMID:
28008661
18.

Janus kinase inhibition for immunosuppression in solid organ transplantation: Is there a role in complex immunologic challenges?

Moore CA, Iasella CJ, Venkataramanan R, Lakkis FG, Smith RB, McDyer JF, Zeevi A, Ensor CR.

Hum Immunol. 2017 Feb;78(2):64-71. doi: 10.1016/j.humimm.2016.12.005. Epub 2016 Dec 18. Review.

PMID:
27998802
19.

A 3-Center Study Reveals New Insights Into the Impact of Non-HLA Antibodies on Lung Transplantation Outcome.

Reinsmoen NL, Mirocha J, Ensor CR, Marrari M, Chaux G, Levine DJ, Zhang X, Zeevi A.

Transplantation. 2017 Jun;101(6):1215-1221. doi: 10.1097/TP.0000000000001389.

PMID:
27973391
20.

Impact of the Pharmacy Practice Model Initiative on Clinical Pharmacy Specialist Practice: An Alternative Viewpoint.

Potter LM, Tichy EM, Horwedel TA, Shullo MA, Ensor CR, Pilch NA, Cochrane AB, Maldonado AQ; 2013 ACCP Certification Affairs Committee, Jacobi J, Sam T.

Pharmacotherapy. 2016 Nov;36(11):e195-e197. doi: 10.1002/phar.1844. No abstract available.

PMID:
27714823
21.

Evaluation of Direct Oral Anticoagulation Therapy in Heart and Lung Transplant Recipients.

Lichvar AB, Moore CA, Ensor CR, McDyer JF, Teuteberg JJ, Shullo MA.

Prog Transplant. 2016 Sep;26(3):263-9. doi: 10.1177/1526924816661951. Review.

PMID:
27597772
22.

De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation.

Morrell MR, Pilewski JM, Gries CJ, Pipeling MR, Crespo MM, Ensor CR, Yousem SA, D'Cunha J, Shigemura N, Bermudez CA, McDyer JF, Zeevi A.

J Heart Lung Transplant. 2014 Dec;33(12):1288-94. doi: 10.1016/j.healun.2014.07.018. Epub 2014 Aug 23.

PMID:
25443870
23.

Verifying information in pharmacy residency applications.

Shermock KM, Ashby DM, Walker CL, Rider SK, Clemente EU, Ensor CR.

Am J Health Syst Pharm. 2014 May 15;71(10):787. doi: 10.2146/ajhp130739. No abstract available.

PMID:
24780484
24.

Characterization, prophylaxis, and treatment of infectious complications in craniomaxillofacial and upper extremity allotransplantation: a multicenter perspective.

Broyles JM, Alrakan M, Ensor CR, Khalifian S, Kotton CN, Avery RK, Brandacher G, Lee WP, Gordon CR.

Plast Reconstr Surg. 2014 Apr;133(4):543e-51e. doi: 10.1097/PRS.0000000000000015. Review.

PMID:
24675206
25.

Domperidone for delayed gastric emptying in lung transplant recipients with and without gastroesophageal reflux.

Lidor AO, Ensor CR, Sheer AJ, Orens JB, Clarke JO, McDyer JF.

Prog Transplant. 2014 Mar;24(1):27-32. doi: 10.7182/pit2014823.

PMID:
24598562
26.

Pharmacist-managed international normalized ratio patient self-testing is associated with increased time in therapeutic range in patients with left ventricular assist devices at an academic medical center.

Bishop MA, Streiff MB, Ensor CR, Tedford RJ, Russell SD, Ross PA.

ASAIO J. 2014 Mar-Apr;60(2):193-8. doi: 10.1097/MAT.0000000000000047.

PMID:
24577370
27.

Streamlining the process for initial review of pharmacy residency applications: an analytic approach.

Ensor CR, Walker CL, Rider SK, Clemente EU, Ashby DM, Shermock KM.

Am J Health Syst Pharm. 2013 Oct 1;70(19):1670-5. doi: 10.2146/ajhp120769.

PMID:
24048603
28.

Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network.

Milfred-Laforest SK, Chow SL, Didomenico RJ, Dracup K, Ensor CR, Gattis-Stough W, Heywood JT, Lindenfeld J, Page RL 2nd, Patterson JH, Vardeny O, Massie BM.

J Card Fail. 2013 May;19(5):354-69. doi: 10.1016/j.cardfail.2013.02.002. Epub 2013 Apr 6.

PMID:
23663818
29.

Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network.

Milfred-LaForest SK, Chow SL, DiDomenico RJ, Dracup K, Ensor CR, Gattis-Stough W, Heywood JT, Lindenfeld J, Page RL 2nd, Patterson JH, Vardeny O, Massie BM.

Pharmacotherapy. 2013 May;33(5):529-48. doi: 10.1002/phar.1295.

PMID:
23649813
30.

Survey of transplant-related pharmacy services at large comprehensive transplant centers in the United States.

Staino C, Lewin JJ 3rd, Nesbit TW, Sullivan B, Ensor CR.

Prog Transplant. 2013 Mar;23(1):23-7. doi: 10.7182/pit2013519.

PMID:
23448816
31.

Alemtuzumab for cytolytic induction of immunosuppression in heart transplant recipients.

Cahoon WD, Ensor CR, Shullo MA.

Prog Transplant. 2012 Dec;22(4):344-9; quiz 350. Review.

PMID:
23187050
32.

Colloids in the intensive care unit.

Kruer RM, Ensor CR.

Am J Health Syst Pharm. 2012 Oct 1;69(19):1635-42. Review.

PMID:
22997116
33.

Proliferation signal inhibitor toxicities after thoracic transplantation.

Ensor CR, Doligalski CT.

Expert Opin Drug Metab Toxicol. 2013 Jan;9(1):63-77. doi: 10.1517/17425255.2012.726219. Epub 2012 Sep 20. Review.

PMID:
22992021
34.

Prophylaxis and treatment of respiratory syncytial virus in adult immunocompromised patients.

Hynicka LM, Ensor CR.

Ann Pharmacother. 2012 Apr;46(4):558-66. doi: 10.1345/aph.1Q553. Epub 2012 Mar 6. Review.

PMID:
22395247
35.

Intravenous neostigmine for postoperative acute colonic pseudo-obstruction.

Elsner JL, Smith JM, Ensor CR.

Ann Pharmacother. 2012 Mar;46(3):430-5. doi: 10.1345/aph.1Q515. Epub 2012 Feb 28. Review.

PMID:
22388328
36.

Generic maintenance immunosuppression in solid organ transplant recipients.

Ensor CR, Trofe-Clark J, Gabardi S, McDevitt-Potter LM, Shullo MA.

Pharmacotherapy. 2011 Nov;31(11):1111-29. doi: 10.1592/phco.31.11.1111. Review.

PMID:
22026398
37.

Capnocytophagia canimorsus sepsis in an asplenic heart transplant candidate with a left ventricular assist system.

Ensor CR, Russell SD, Wittstein IS, Conte JV.

Prog Transplant. 2011 Jun;21(2):121-3.

PMID:
21736240
38.

Development and implementation of a pharmacist-managed inpatient anticoagulation monitoring program.

Wellman JC, Kraus PS, Burton BL, Ensor CR, Nesbit TW, Ross PA, Thomas ML, Streiff MB.

Am J Health Syst Pharm. 2011 May 15;68(10):934-9. doi: 10.2146/ajhp100242.

PMID:
21546645
39.

Impact of Early Postoperative Hydrocortisone Administration in Cardiac Surgical Patients After Cardiopulmonary Bypass.

Ensor CR, Sabo RT, Voils SA.

Ann Pharmacother. 2011 Feb;45(2):189-94. doi: 10.1345/aph.1P468.

PMID:
21304031
40.

Pharmacotherapy for mechanical circulatory support: a comprehensive review.

Ensor CR, Paciullo CA, Cahoon WD Jr, Nolan PE Jr.

Ann Pharmacother. 2011 Jan;45(1):60-77. doi: 10.1345/aph.1P459. Epub 2011 Jan 4. Review.

PMID:
21205950
41.

Proper analysis and interpretation of the stability of levothyroxine sodium 0.4 microg/mL in 0.9% sodium chloride injection.

Ensor CR, Shermock KM.

Prog Transplant. 2010 Sep;20(3):203, 208; author reply 208. No abstract available.

PMID:
20929103
42.

Tonapofylline: a selective adenosine-1 receptor antagonist for the treatment of heart failure.

Ensor CR, Russell SD.

Expert Opin Pharmacother. 2010 Oct;11(14):2405-15. doi: 10.1517/14656566.2010.514605. Review.

PMID:
20807184
43.

The risk of ventricular-assist device infections differs by device type.

Ensor CR, Shiekh F, Conte JV.

Clin Infect Dis. 2010 Sep 1;51(5):632-3; author reply 633-4. doi: 10.1086/655767. No abstract available.

PMID:
20684681
44.

Antithrombotic therapy for the CardioWest temporary total artificial heart.

Ensor CR, Cahoon WD, Crouch MA, Katlaps GJ, Hess ML, Cooke RH, Gunnerson KJ, Kasirajan V.

Tex Heart Inst J. 2010;37(2):149-58. Review.

45.

Induction immunosuppression for orthotopic heart transplantation: a review.

Ensor CR, Cahoon WD Jr, Hess ML, Kasirajan V, Cooke RH.

Prog Transplant. 2009 Dec;19(4):333-41; quiz 342. Review.

PMID:
20050456
46.

Current controversies in the pharmacogenomics of clopidogrel.

Ensor CR, Cahoon WD Jr.

Prog Cardiovasc Nurs. 2009 Sep;24(3):105-9. doi: 10.1111/j.1751-7117.2009.00044.x. Review. No abstract available.

PMID:
19737169
47.

Erythropoiesis-stimulating agents: creation and validation of a computerized prescriber order entry alert.

Ensor CR, Kockler DR, Dugger RW, Hylton-Gravatt LA.

Ann Pharmacother. 2009 Jun;43(6):1143-4. doi: 10.1345/aph.1L714. Epub 2009 May 19. No abstract available.

PMID:
19458108
48.

Letter: Correction for haemolysis in the zinc sulphate turbidity test.

Ensor CR.

Vet Rec. 1975 Mar 15;96(11):255. No abstract available.

PMID:
1119050
49.

Pyrazapon (CI-683): a new antianxiety agent.

Poschel BP, McCarthy DA, Chen G, Ensor CR.

Psychopharmacologia. 1974 Feb 27;35(3):257-71. No abstract available.

PMID:
4208323
50.

Effects of L-dopa and L-3-methoxytyrosine on D-methamphetamine-induced motor activity and seizures induced by electroshock.

McLean JR, Ensor CR, McCarthy DA, Bohner B, Potoczak D.

Proc Soc Exp Biol Med. 1973 Sep;143(4):1083-7. No abstract available.

PMID:
4743685

Supplemental Content

Loading ...
Support Center